Expensive, exploratory research biopsies overused in early studies of new cancer drugs

Early trials of new cancer drugs often require extra biopsies to determine the drugs' biochemical and physiological effects. A new study shows that this costly, risky and often painful process has had no impact on subsequent drug development.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1NQX5DD